Gita Massey
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Gita Massey has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
Alden Chesney
Division of Clinical Pathology Virginia Commonwealth University Medical Center Richmond Virginia USA
2 shared publications- Yaddanapudi Ravindranath
Wayne State University School of Medicine Detroit Michigan USA
2 shared publications Ahmad Al‐Huniti
Mayo Clinic Pediatric Hematology Oncology Rochester Minnesota USA
1 shared publicationAndrew Tran
Division of Hematology/Oncology Department of Pediatrics University of Arkansas for Medical Sciences Little Rock Arkansas USA
1 shared publicationAutumn Atkinson
Department of Pediatrics University of Texas Health Science Center Houston Texas USA
1 shared publication- Bryan A. Sisk
Division of Hematology and Oncology, Department of Pediatrics, Washington University School of Medicine, St. Louis, MO, USA
1 shared publication
Latest Publications
- 17 March 2025
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 72 (6) , e31661
Sociodemographic Characteristics of Patients Seen at Vascular Anomaly Centers in the United States
Patients with vascular anomalies (VAs) require expert multidisciplinary care. No prior studies have characterized the sociodemographic characteristics across multiple VA centers. We collected data on 5783 patients receiving care at 20 VA centers between July 1, 2020 through December 31, 2022. Male patients were underrepresented compared to the state‐level census data at 17/20 centers. Black and Asian patients were underrepresented at 14/20 and 12/20 centers, respectively. The median distance to the hospital was 48 miles, and median age was 12.0 years. These data suggest that race, sex, age, and distance from the hospital could impede the ability to access expert VA care.
- 17 March 2025
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 72 (6) , e31661
Sociodemographic Characteristics of Patients Seen at Vascular Anomaly Centers in the United States
Patients with vascular anomalies (VAs) require expert multidisciplinary care. No prior studies have characterized the sociodemographic characteristics across multiple VA centers. We collected data on 5783 patients receiving care at 20 VA centers between July 1, 2020 through December 31, 2022. Male patients were underrepresented compared to the state‐level census data at 17/20 centers. Black and Asian patients were underrepresented at 14/20 and 12/20 centers, respectively. The median distance to the hospital was 48 miles, and median age was 12.0 years. These data suggest that race, sex, age, and distance from the hospital could impede the ability to access expert VA care.
- 24 March 2024
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 71 (6) , e30955
Congenital dyserythropoietic anemia type IV with KLF1 E325K mutation: A new case with dysmorphic male genitalia
- 24 March 2024
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 71 (6) , e30955
Congenital dyserythropoietic anemia type IV with KLF1 E325K mutation: A new case with dysmorphic male genitalia
- Open Access
- 28 July 2023
- Published by Wiley
Congenital Dyserythropoietic Anemia Type IV with KLF1 E325K Mutation --
Congenital Dyserythropoietic Anemia Type IV (CDA-IV) is still an emerging new disease with approximately 10 cases reported over the past three decades. CDA-IV is known to be caused by a specific mutation in exon 3 of KLF1, an erythroid transcription factor KLF1 with substitution of glutamic acid with lysine at residue 325 (KLF1 E325K). Because of the rarity of this disorder the presenting features are incompletely defined; especially the non-erythroid comorbidities. Here we report a new case, a male child, presenting with fetal hydrops and dysmorphic external genitalia.
- 28 July 2023
- Published by Wiley
Open AccessCongenital Dyserythropoietic Anemia Type IV with KLF1 E325K Mutation --
Congenital Dyserythropoietic Anemia Type IV (CDA-IV) is still an emerging new disease with approximately 10 cases reported over the past three decades. CDA-IV is known to be caused by a specific mutation in exon 3 of KLF1, an erythroid transcription factor KLF1 with substitution of glutamic acid with lysine at residue 325 (KLF1 E325K). Because of the rarity of this disorder the presenting features are incompletely defined; especially the non-erythroid comorbidities. Here we report a new case, a male child, presenting with fetal hydrops and dysmorphic external genitalia.
- Open Access
- 1 December 2022
- Published by MDPI AG in Hematology Reports
- Vol. 14 (4) , 349-357
Medich Giant Platelet Syndrome: An Evolving Qualitative and Quantitative Platelet Disorder
Qualitative platelet disorders remain rare and varied. We describe here 2 additional patients with giant platelets, thrombocytopenia, deficiency in alpha granules and the presence of membranous inclusions within the cytoplasm. Collectively known as Medich syndrome, we further elucidated structural and clinical features of this rare syndrome. Platelets obtained from 2 patients with macro-thrombocytopenia were evaluated by electron microscopy. Structural findings were correlated with clinical characteristics. The defining morphologic feature found in the platelets of these patients is the presence of long, tubular inclusions consisting of several layers of membrane wrapped around a core of cytoplasm. These inclusions may deform the discoid shape of the platelet. In addition, abnormal giant alpha granules are present. Clinically all patients in the current report and review of the literature had mucosal bleeding and were often misdiagnosed as having immune related thrombocytopenia. To date five cases of Medich giant platelet syndrome have been reported. The cases are unified by the ultrastructural findings of abnormal alpha granules and unusual cytoplasmic scrolls. All patients experienced mucosal bleeding, however many clinical, biologic and genetic characteristics of this rare disorder remain to be determined.
- 1 December 2022
- Published by MDPI AG in Hematology Reports
- Vol. 14 (4) , 349-357
Open AccessMedich Giant Platelet Syndrome: An Evolving Qualitative and Quantitative Platelet Disorder
Qualitative platelet disorders remain rare and varied. We describe here 2 additional patients with giant platelets, thrombocytopenia, deficiency in alpha granules and the presence of membranous inclusions within the cytoplasm. Collectively known as Medich syndrome, we further elucidated structural and clinical features of this rare syndrome. Platelets obtained from 2 patients with macro-thrombocytopenia were evaluated by electron microscopy. Structural findings were correlated with clinical characteristics. The defining morphologic feature found in the platelets of these patients is the presence of long, tubular inclusions consisting of several layers of membrane wrapped around a core of cytoplasm. These inclusions may deform the discoid shape of the platelet. In addition, abnormal giant alpha granules are present. Clinically all patients in the current report and review of the literature had mucosal bleeding and were often misdiagnosed as having immune related thrombocytopenia. To date five cases of Medich giant platelet syndrome have been reported. The cases are unified by the ultrastructural findings of abnormal alpha granules and unusual cytoplasmic scrolls. All patients experienced mucosal bleeding, however many clinical, biologic and genetic characteristics of this rare disorder remain to be determined.
- 2 June 2020
- Published by Wolters Kluwer Health in Journal of Pediatric Hematology/Oncology
- Vol. 43 (4) , e543-e545
Pediatric Paroxysmal Nocturnal Hemoglobinuria Presenting as Acute Kidney Injury
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare disease characterized by variable and diverse symptoms including the classic triad of hemolytic anemia, thrombosis, and bone marrow failure. It is a disorder primarily seen in the adult population. The authors report a unique case of an 8-year-old girl diagnosed with PNH after initially presenting with a febrile illness and acute kidney injury. Though rare in children, PNH should remain in the differential diagnosis of a child presenting with acute kidney injury. The disease has serious long-term complications, mandating timely diagnosis and appropriate therapy.
- 2 June 2020
- Published by Wolters Kluwer Health in Journal of Pediatric Hematology/Oncology
- Vol. 43 (4) , e543-e545
Pediatric Paroxysmal Nocturnal Hemoglobinuria Presenting as Acute Kidney Injury
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare disease characterized by variable and diverse symptoms including the classic triad of hemolytic anemia, thrombosis, and bone marrow failure. It is a disorder primarily seen in the adult population. The authors report a unique case of an 8-year-old girl diagnosed with PNH after initially presenting with a febrile illness and acute kidney injury. Though rare in children, PNH should remain in the differential diagnosis of a child presenting with acute kidney injury. The disease has serious long-term complications, mandating timely diagnosis and appropriate therapy.
- 1 November 1994
- Published by Springer Nature in Pediatric Radiology
- Vol. 24 (7) , 494-495
Acute monoblastic leukemia presenting with pericardial effusion and cardiac tamponade
A previously healthy young child presented with a large pericardial effusion and cardiac tamponade. The chest radiograph was key to the recognition of the pericardial effusion. Cytologic examination of the pericardial fluid ultimately established the diagnosis of acute monoblastic leukemia in the absence of associated clinical or laboratory findings. The pericardial fluid was vital for leukemic cell classification because the bone marrow has hypocellular and non-diagnostic. This presentation of acute monoblastic leukemia is very rare, and in the three previously reported pediatric cases has been associated either with peripheral blasts or a history of preleukemia. When the cardiac configuration suggests pericardial effusion in a previously healthy young child, the diagnosis of new onset leukemia should be considered.
- 1 November 1994
- Published by Springer Nature in Pediatric Radiology
- Vol. 24 (7) , 494-495
Acute monoblastic leukemia presenting with pericardial effusion and cardiac tamponade
A previously healthy young child presented with a large pericardial effusion and cardiac tamponade. The chest radiograph was key to the recognition of the pericardial effusion. Cytologic examination of the pericardial fluid ultimately established the diagnosis of acute monoblastic leukemia in the absence of associated clinical or laboratory findings. The pericardial fluid was vital for leukemic cell classification because the bone marrow has hypocellular and non-diagnostic. This presentation of acute monoblastic leukemia is very rare, and in the three previously reported pediatric cases has been associated either with peripheral blasts or a history of preleukemia. When the cardiac configuration suggests pericardial effusion in a previously healthy young child, the diagnosis of new onset leukemia should be considered.